+ All Categories
Home > Documents > The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

Date post: 06-Jan-2018
Category:
Upload: paul-baker
View: 220 times
Download: 3 times
Share this document with a friend
Description:
3 SampleSpain Population (n) Projected Number of Spain Adults Total Spain Adults 5, M Experiencing Pain (in the past month)* M Severe K Moderate M Mild M Severe: Rx81572 K OTC ‡ Only10 †† 73 K Untreated9 †† 68 K Moderate: Rx M OTC ‡ Only K Untreated91622 K Mild: Rx77551 K OTC ‡ Only81549 K Untreated56374 K Spain Sample Size Key segments of the Pain market are represented by the following sample sizes: †† Caution: extremely small base size ‡ OTC/Herbal Products *Excludes dental problems, headache, menstrual pain or migraine only.
13
The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010
Transcript
Page 1: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

The Pain Market:

Spain Core Therapeutic ReportNational Health and Wellness Survey 2010

Page 2: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

2

Method and Sample

Data Collection+ Survey administered via the Internet since 2002+ Data collected during March-May 2010+ Countries: Spain

Sample+ Adults 18+ years of age+ Sample drawn from the Internet panel maintained by Lightspeed Research+ Invitations to participate sent to a sample stratified according to:

– Gender– Age

Results are projected to reflect the total population using known population incidences for key subgroups

+ Weighting Variables: Gender and age+ From the International Data Base of the U.S. Census Bureau and

Organization for Economic Cooperation and Development

Page 3: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

3

Sample Spain Population

(n)Projected Number of

Spain AdultsTotal Spain Adults 5,039 35.4 MExperiencing Pain (in the past month)* 868 6.1 MSevere 100 714 K

Moderate 554 3.9 M

Mild 214 1.5 M

Severe:Rx 81 572 K

OTC‡ Only 10†† 73 K

Untreated 9†† 68 K

Moderate:Rx 357 2.6 M

OTC‡ Only 106 710 K

Untreated 91 622 K

Mild:Rx 77 551 K

OTC‡ Only 81 549 K

Untreated 56 374 K

Spain Sample Size

Key segments of the Pain market are represented by the following sample sizes:

††Caution: extremely small base size ‡OTC/Herbal Products*Excludes dental problems, headache, menstrual pain or migraine only.

Page 4: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

Spain Pain Prevalence 2010

4††Base too small to project to total population (n<15) ‡OTC/Herbal ProductsQuestions reference for this slide include: HH10, HH20, PN5, PN15, PN20, PN95, PN120, DB40 (See Appendix)

*Excludes dental problems, headache, menstrual pain or migraine only.

Experiencing Pain (in the past month)*

6.1 M (17%)(n=868)

SEVERE714 K (12%)

(n=100)

Use Rx572 K 80%

(n=81)

OTC‡ Only73 K 10%

(n=10††)

Untreated68 K 10%

(n=9††)

MODERATE3.9 M (64%)

(n=554)

Use Rx2.6 M 66%

(n=357)

OTC‡ Only710 K 18%

(n=106)

Untreated622 K 16%

(n=91)

MILD1.5 M (24%)

(n=214)

Use Rx551 K 37%

(n=77)

OTC‡ Only549 K 37%

(n=81)

Untreated374 K 25%

(n=56)

Total Spain Adults Population

35.4 M(n=5,039)

Page 5: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

All OTC‡ Users191 K (27%)

(n=26†)

Total Use Rx572 K 80%

(n=81)

Spain Pain Brand Usage 2010

Experiencing Pain (in the past month)*6.1 M (17%) (n=868)

SEVERE714 K (12%)

(n=100)

*Excludes dental problems, headache, menstrual pain or migraine only.‡OTC/Herbal Products†Caution: small base (n<30)††Base too small to project to total population (n<15) Questions reference for this slide include: HH10, HH20, PN5, PN15, PN20, PN30, PN95, PN100, PN120 , DB40 (See Appendix)

5

Specific Rx Therapies Used(By Class of Drug)

Strong Opioids †† (n=12†) Weak Opioids 294 K 51% (n=39) NSAIDs 362 K 63% (n=52) COX-2s †† (n=7†) Anticonvulsants 155 K 27% (n=23†) Amitriptyline †† (n=0†) Analgesics †† (n=14†) All Other Pain Medications †† (n=4†)

Top OTC‡ Therapies Used(Unaided)

Ibuprofen Products †† (n=13†) Acetaminophen /Paracetamol †† (n=2†) Aspirin Products †† (n=0†)Diclofenac †† (n=0†) Others(inc. combination OTCs‡) †† (n=10†)

MODERATE3.9 M (64%)

(n=554)

Total Use Rx2.6 M 66%

(n=357)

Total OTC‡ Users 1.3 M (32%)

(n=180)

MILD1.5 M (24%)

(n=214)

Total Use Rx551 K 37%

(n=77)

Total OTC‡ Users 620 K (42%)

(n=91)

Specific Rx Therapies Used(By Class of Drug)

Strong Opioids †† (n=3†) Weak Opioids 1.1 M 43% (n=143) NSAIDs 1.8 M 71% (n=261) COX-2s 126 K 5% (n=20†) Anticonvulsants 245 K 10% (n=34) Amitriptyline †† (n=0†) Analgesics 351 K 14% (n=55) All Other Pain Medications †† (n=13†)

Specific Rx Therapies Used(By Class of Drug)

Strong Opioids †† (n=0†) Weak Opioids 126 K 23% (n=18†) NSAIDs 418 K 76% (n=60) COX-2s †† (n=2†) Anticonvulsants †† (n=2†) Amitriptyline †† (n=0†) Analgesics †† (n=5†) All Other Pain Medications †† (n=3†)

Top OTC‡ Therapies Used(Unaided)

Ibuprofen Products 824 K 66% (n=124) Acetaminophen /Paracetamol 406 K 32% (n=59) Aspirin Products 187 K 15% (n=23†)Diclofenac †† (n=5†) Others(inc. combination OTCs‡) 621 K 50% (n=93)

Top OTC‡ Therapies Used(Unaided)

Ibuprofen Products 392 K 63% (n=59) Acetaminophen /Paracetamol 167 K 27% (n=26†) Aspirin Products 128 K 21% (n=18†)Diclofenac †† (n=3†) Others(inc. combination OTCs‡) 292 K 47% (n=44)

Total Spain Adults Population35.4 M (n=5,039)

Page 6: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

6

Experiencing Pain in Past Month*

Total Rx Users

Strong Opioids

Weak Opioids NSAIDs COX-2s

AntiConv-ulsants

Amitri-ptyline Analgesics

All Other Pain

Medication3.7 M 125 K 1.5 M 2.6 M 182 K 412 K 0 K 488 K 144 K

(n=515) (n=15†) (n=200) (n=373) (n=29†) (n=59) (n=0††) (n=74) (n=20†)

Duration of Rx Usage (mean # of months)Experiencing Pain (in the past month)* 67.8 26.7 59.3 68.8 33.2 33.4 - 64.1 65.5Severe 81.1 32.6 79.7 92.3 57.3 40.5 - 55.3 94.5Moderate 69.9 7.5 57.1 69.4 26.9 30.2 - 69.5 44.0Mild 44.4 - 31.7 46.1 7.1 9.4 - 33.5 93.9% Extremely/Very SatisfiedExperiencing Pain (in the past month)* 40% 31% 31% 43% 37% 46% - 45% 52%Severe 32% 39% 29% 28% 31% 33% - 28% 79%Moderate 40% - 32% 43% 40% 51% - 47% 23%Mild 55% - 21% 59% 31% 100% - 84% 100%# Days/Mo. Report Taking Rx (mean)Experiencing Pain (in the past month)* 16 21 15 12 13 24 - 16 16Severe 23 21 20 18 15 25 - 18 19Moderate 16 20 14 12 14 24 - 16 20Mild 8 - 8 7 8 15 - 14 4% Requested Specific RxExperiencing Pain (in the past month)* 29% 25% 26% 28% 14% 11% - 29% 26%Severe 27% 24% 30% 26% 17% 16% - 33% 46%Moderate 28% 26% 22% 27% 10% 9% - 27% 24%Mild 36% - 45% 35% 44% - - 40% 17%

Pain Prescription Medication Usage

Pain Prescription Medication Usage(Experiencing Pain and using Rx)*

*Excludes dental problems, headache, menstrual pain or migraine only. Caution: †small base size; ††extremely small base size*Note: mean satisfaction taken into consideration if multiple pain therapies are used.PN35: You indicated you use the following prescription medication(s). Did you request this specific brand from your doctor?.PN40: How many years and/or months have you been using these prescription medication(s)? If you have been using it less than 1 month, please enter a “0” for ”years” and “1” for “months”.PN45: How many days did you use these prescription medication(s) in the past month?PN50: How satisfied are you with these prescription medication(s)?Based on 7 point scale where 1=Extremely dissatisfied and 7=Extremely satisfied In 2010, a "stacked" method was used for determining overall medication satisfaction

Page 7: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

Comparison of SF-12v2 Physical/Mental Health Scores by Subgroups to Total Population Score

7

‡OTC/Herbal Products Caution: extremely small base size *Excludes dental problems, headache, menstrual pain or migraine only.General Health - summary scores.Letters indicate statistically significant difference @ 95% confidence level between subgroups

Physical Health Summary Mental Health Summary

Spain Total Population Score Mean=48.4

Total Spain Adults(35.4 M; n=5,039)

Experiencing Pain (in the past month)*(6.1 M; n=868)

Severe (C)

(714 K; n=100)

Mild (E)

(1.5 M; n=214)

Moderate (D)

(3.9 M; n=554)

Expe

rienc

ing

Pain

(in

the

past

mon

th)*

Rx (L)

(551 K; n=77)OTC‡ Only (M)

(549 K; n=81)Untreated (N)

(374 K; n=56)

Seve

re:

Spain Total Population Score Mean=47.4

C

Rx (F)

(572 K; n=81)OTC‡ Only (G)

(73 K; n=10)Untreated (H)

(68 K; n=9)Rx (I)

(2.6 M; n=357)OTC‡ Only (J)

(710 K; n=106)Untreated (K)

(622 K; n=91)Mod

erat

e:M

ild:

CD

I

I

L

C

CD

Page 8: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

8

Pain Interfered With Normal Work During The Past 4 Weeks

Total Spain Adults

Exp. Pain (in the past

month)*

Experiencing Pain (in the past month)* Severe Moderate Mild

Severe (C)

Moderate(D)

Mild(E)

Rx(F)

OTC‡ Only(G)

Untr-eated

(H)Rx(I)

OTC‡ Only(J)

Untr-eated

(K)Rx(L)

OTC‡ Only(M)

Untr-eated

(N)35.4 M 6.1 M 714 K 3.9 M 1.5 M 572 K 73 K 68 K 2.6 M 710 K 622 K 551 K 549 K 374 K

(n=5,039) (n=868) (n=100) (n=554) (n=214) (n=81) (n=10) (n=9) (n=357) (n=106) (n=91) (n=77) (n=81) (n=56)General HealthExtremely 2% 6% 35%DE 2% 0% 34% 30% 53% 3% 2% - 1% - - Quite a bit 8% 23% 48%DE 26%E 4% 52% 34% 26% 32%JK 15% 15% 5% 4% 2%Moderately 17% 27% 13% 31%CE 22% 11% 27% 11% 32% 27% 31% 28% 16% 19%A little bit 32% 36% 4% 34%C 58%CD 3% 9% 10% 30% 40% 42%I 57% 61% 56%No at all 42% 8% - 7% 16%D - - - 3% 16%I 11%I 9% 19% 23%L

Pain Interfered With Normal Work During The Past 4 Weeks

‡OTC/Herbal Products Caution: extremely small base size Zero % implies a very small value less than 0.5%*Excludes dental problems, headache, menstrual pain or migraine only. GH25: During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)?(1-5 Scale: 1=Excellent and 5=No at all)Letters indicate statistically significant difference @ 95% confidence level between subgroups

Page 9: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

9

Physical Health Or Emotional Problems Interfered With Social Activities During The Past 4 Weeks

Total Spain Adults

Exp. Pain (in the past

month)*

Experiencing Pain (in the past month)* Severe Moderate Mild

Severe (C)

Moderate(D)

Mild(E)

Rx(F)

OTC‡ Only(G)

Untr-eated

(H)Rx(I)

OTC‡ Only(J)

Untr-eated

(K)Rx(L)

OTC‡ Only(M)

Untr-eated

(N)35.4 M 6.1 M 714 K 3.9 M 1.5 M 572 K 73 K 68 K 2.6 M 710 K 622 K 551 K 549 K 374 K

(n=5,039) (n=868) (n=100) (n=554) (n=214) (n=81) (n=10) (n=9) (n=357) (n=106) (n=91) (n=77) (n=81) (n=56)General HealthAll of the time 2% 4% 24%DE 2% 1% 27% 8% 11% 3% - 1% - 3% - Most of the time 8% 13% 29%DE 12%E 7% 30% 27% 18% 14% 8% 10% 10% 5% 7%Some of the time 19% 27% 28% 29% 22% 26% 38% 28% 34%JK 23% 16% 22% 20% 26%A little of a time 30% 30% 13% 31%C 36%C 14% 17% - 28% 34% 42%I 42% 38% 25%None of the time 41% 25% 7% 24%C 33%CD 3% 9% 42% 20% 35%I 32%I 26% 34% 42%

Physical Health Or Emotional Problems Interfered WithSocial Activities During The Past 4 Weeks

‡OTC/Herbal Products Caution: extremely small base size *Excludes dental problems, headache, menstrual pain or migraine only. GH35: During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? (1-5 Scale: 1=all of the time and 5=None of the time)Letters indicate statistically significant difference @ 95% confidence level between subgroups

Page 10: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

10

‡OTC/Herbal Products ^Differing base size Caution: extremely small base size *Excludes dental problems, headache, menstrual pain or migraine only. All the figures are for presently Full Time employees apart from activity impairmentDE30: What is your employment status?WPPCTWRK: Percentage work time missed due to health. WPIMPAIR: Percentage impairment while working due to health.WPWRKIMP: Percentage overall work impairment due to health. WPACTIMP: Percentage activity impairment due to health.(0-10 Scale: 0=health problems had no effect on my work and 10=health problems completely prevented me from working)Letters indicate statistically significant difference @ 95% confidence level between subgroups

Spain Adult Work Productivity and Activity Impairment

Total Spain Adults

Exp. Pain (in the past

month)*

Experiencing Pain (in the past month)* Severe Moderate Mild

Severe (C)

Moderate(D)

Mild(E)

Rx(F)

OTC‡ Only(G)

Untr-eated

(H)Rx(I)

OTC‡ Only(J)

Untr-eated

(K)Rx(L)

OTC‡ Only(M)

Untr-eated

(N)35.4 M 6.1 M 714 K 3.9 M 1.5 M 572 K 73 K 68 K 2.6 M 710 K 622 K 551 K 549 K 374 K

(n=5,039) (n=868) (n=100) (n=554) (n=214) (n=81) (n=10) (n=9) (n=357) (n=106) (n=91) (n=77) (n=81) (n=56)Employed full time 37% 34% 20% 33%C 45%CD 25% - - 29% 43%I 37% 41% 50% 44%Absenteeism^% work time missed due to health – past 7 days (mean)

4.6 12.7 41.8DE 12.8 6.3 41.8 - - 17.7J 2.3 11.2 7.1 5.7 6.1

Presenteeism^% impairment while working due to health (mean)

17.1 25.1 38.3 25.4 22.9 38.3 - - 28.6 21.1 22.1 25.2 21.4 22.3

Work Productivity Loss^% overall work impairment due to health (mean)

20.1 33.6 62.8DE 33.9 26.6 62.8 - - 40.1J 21.4 30.5 29.6 24.4 26.3

Activity Impairment% activity impairment due to health (mean)

25.6 41.7 74.4DE 41.6E 26.0 79.2 61.5 47.7 47.2JK 27.0 35.2J 30.6N 24.9 20.9

Spain Adult Work Productivity and Activity Impairment

Page 11: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

61%

40%

29%

35%

17%

12%

10%

10%

23%

7%

Type of Pain Conditions

11*Excludes dental problems, headache, menstrual pain or migraine only.PN15: Please indicate which of the following conditions have caused you to feel pain in the past month.Letters indicate statistically significant difference @ 95% confidence level between subgroups

Pain population, prevalence of conditions causing pain by pain severity(Respondents with pain in the past month)

Experience Pain(in the past month)*

(6.1 M; n=868)Moderate (D)

(3.9 M; n=554)Mild (E)

(1.5 M; n=214)

Experiencing Pain (in the past month)*

Back pain

Headache

Shoulder pain/stiffness

Arthritis pain

Neck pain

Migraine

Dental pain

Sprains or strains

Surgery or medical procedure

Joint pain

13%

15%

15%

12%

17%

28%

15%

13%

16%

29%

67%

66%

66%

64%

66%

57%

71%

57%

67%

63%

19%

19%

19%

24%

16%

15%

14%

31%

17%

8%

Severe (C)

(714 K; n=100)

Page 12: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

12

Experience Symptoms/Side Effects – Among Rx Opioid Users

Experience Symptoms/Side Effects – Among Rx Opioid Users(Respondents with pain in the past month (qualified respondents), taking opioid medications, experiencing symptoms)

Nausea

Experience Pain(in the past month)*

(239 K; n=37)Severe (C)

(77 K; n=12††)Moderate (D)

(149 K; n=23†)Mild (E)

(13 K; n=2††)

Experiencing Pain (in the past month)*

Abdominal pain / discomfort

Dizziness

Constipation

Sleepiness

Trouble thinking clearly

Other digestive symptoms

Vomiting

Feeling moody, irritable, anxious, or restless

Diarrhea

Bloating

Other

None of above

Caution: †small base size; ††extremely small base size *Excludes dental problems, headache, menstrual pain or migraine only.PN60: Please indicate the symptoms you experience while taking <insert name(s) of opioid medication> for your pain?No statistically significant difference @ 95% confidence level between subgroups

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Page 13: The Pain Market: Spain Core Therapeutic Report National Health and Wellness Survey 2010.

13

CONTACT INFORMATION Global Headquarters

Kantar Health Health Sciences Practice1 Independence Way, Suite 220, Princeton, NJ  08540Telephone: +1 (609) 720 5480 Fax: +1 (609) 720 5481

11 Madison Avenue, 12th Floor, New York, NY 10010 Telephone: +1 (212) 706 4279 Fax: +1 (212) 647 7659

Spain NHWS 2010 Data

When referencing data from this report please use the following citation:

+ Kantar Health. September 2010. NATIONAL HEALTH AND WELLNESS SURVEY, 2010 [Spain]. Princeton, NJ.


Recommended